Overall revenue was down 5.2% to $32.24 billion, which reflected primarily a reduction in fiscal 2024 revenue following BAT's 2023 divestitures of business in Russia and Belarus in response to ...

Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...

Denver City Council’s crusade against flavored nicotine products continues to vex those of us who, as a matter of civic ...

Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...

Reginaldo Dobrowolski, Vice President and Controller at Philip Morris International Inc. (NYSE:PM), recently sold a ...

Phillip Morris International has reported strong duty-free revenue growth in the company’s 2024 financial results, with the numbers buoyed by a surge in demand for smoke-free products.

Philip Morris International Shares Surge as Transformation Continues. Is It Too Late to Buy the Stock?

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. Read more to ...

Last month, the FDA authorized the sale of 10 Zyn flavors, marking the first time the agency has backed the public health ...

The smoke-free champion marked an 11% rise in its duty-free business, which offset challenges in Australia and Korea’s ...